Avitene Ultrafoam: payments to doctors
Payments that named Avitene Ultrafoam as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $191K
- Providers
- 193
- Transactions
- 224
- Average per transaction
- $854
The per-transaction average — $854 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 193 providers the average total is $991, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| C. R. Bard, Inc. & Subsidiaries | $169,889 | 88.8% |
| Davol Inc. | $10,944 | 5.7% |
| BD | $10,387 | 5.4% |